Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SEMAFOOT2 Pilot Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

NCT07581145 is registered in ClinicalTrials.gov with Ole Lander Svendsen as lead sponsor.

NCT NCT07581145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07581145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SEMAFOOT2 Pilot Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
Lead sponsor
Ole Lander Svendsen
Phase
Phase 3
Overall status
Recruiting
Start date
April 24, 2026
Completion date
December 31, 2029
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

foot ulcer due to type 2 diabetes mellitus